Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

2 results
Display

Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis

Arivarasan K, Bhardwaj V, Sud S, Sachdeva S, Puri AS

Pyoderma gangrenosum (PG) is an uncommon extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite limited published literature, biologics have caused a paradigm shift in the management of this difficult-to-treat skin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis

Singh J, Puri AS, Sachdeva S, Sakhuja P, Arivarasan K

Tumor necrosis factor-α inhibitors are now considered as standard therapy for patients with severe inflammatory bowel disease who do not respond to corticosteroids, but they carry a definite risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr